Literature DB >> 25636031

Hepatocellular carcinoma: stiffness value and ratio to discriminate malignant from benign focal liver lesions.

Qiang Lu1, Wenwu Ling, Changli Lu, Jiawu Li, Lin Ma, Jierong Quan, Du He, Jianping Liu, Jiaying Yang, Tianfu Wen, Hong Wu, Hongguang Zhu, Yan Luo.   

Abstract

PURPOSE: To investigate the use of stiffness value and stiffness ratio (ratio of lesion to background liver parenchyma values) to discriminate malignant from benign focal liver lesions by using histologic results as the reference standard.
MATERIALS AND METHODS: This study was approved by the institutional review board, and written informed consent was obtained. Three hundred seventy-three patients with focal liver lesions proven at histologic examination underwent measurement of liver stiffness with elastography point quantification. First, stiffness values in two regions of the background liver parenchyma (at 0.5-2 cm and >2 cm from the lesion periphery) near 163 hepatocellular carcinomas were analyzed to determine a reference background liver for calculating the stiffness ratio. Second, the use of the lesion stiffness value and the stiffness ratio for prediction of liver malignancy was investigated in a cohort of patients with 58 benign and 201 malignant lesions. Results were validated in another independent cohort of patients with 25 benign and 89 malignant lesions by using analysis of the area under the receiver operating characteristic (AUC) curve.
RESULTS: The coefficient of variation for the background liver at 0.5-2 cm from the lesion was higher (196%) than that at greater than 2 cm from the lesion (66%). In the development phase, diagnostic accuracy with use of the stiffness value was significantly higher than that with use of the stiffness ratio for discrimination of malignant from benign lesions (AUC, 0.86 vs 0.66, respectively; P < .001). Diagnostic performance with the stiffness value was lower than that with the stiffness ratio (AUC, 0.53 vs 0.86, respectively; P < .001) for discrimination of cirrhotic nodules from other benign lesions. Diagnostic performance with the stiffness value was significantly lower than that with the stiffness ratio (AUC, 0.58 vs 0.71 respectively; P = .007) for discrimination of metastasis from primary liver cancers. In the validation phase, similar findings were revealed for the discrimination of malignant from benign lesions (AUC, 0.87 vs 0.67; P < .001) and discrimination between metastasis and primary liver cancers (AUC, 0.49 vs 0.73; P < .001).
CONCLUSION: Use of stiffness values measured in the liver parenchyma at more than 2 cm from the lesion allowed better diagnostic performance than did values measured in a region closer to the tumor. Stiffness value was more accurate than stiffness ratio for differentiation of malignant from benign focal liver lesions, but the stiffness ratio might be useful for subclassification of benign and malignant lesions. Online supplemental material is available for this article. RSNA, 2015

Entities:  

Mesh:

Year:  2015        PMID: 25636031     DOI: 10.1148/radiol.14131164

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  14 in total

1.  2D shear-wave ultrasound elastography (SWE) evaluation of ablation zone following radiofrequency ablation of liver lesions: is it more accurate?

Authors:  Xiao W Bo; Xiao L Li; Hui X Xu; Le H Guo; Dan D Li; Bo J Liu; Dan Wang; Ya P He; Xiao H Xu
Journal:  Br J Radiol       Date:  2016       Impact factor: 3.039

2.  Noninvasive assessment of liver function reserve with fluorescent dosimetry of indocyanine green.

Authors:  Pei-Chun Wu; Lun-Zhang Guo; Shan Yu; Ning Zeng; Yu-Cheng Liu; Jia Yu; Zhiming Zhang; Ke Lu; Liangyu Sun; Chunfei Wang; Yu-Han Chang; Yin-Lin Lu; Yu-Fang Shen; Sheng Tai; Yueh-Hsun Chuang; Ja-An Annie Ho; Kai-Wen Huang; Yao-Ming Wu; Tzu-Ming Liu
Journal:  Biomed Opt Express       Date:  2022-03-10       Impact factor: 3.562

3.  Evaluation of the diagnostic efficacy of strain elastography in infertile population with normal and abnormal semen parameters.

Authors:  Faruk Küçükdurmaz; Mehmet Akif Sarıca; Özcan Emre; Murat Baykara; Betül Kızıldağ; Sefa Resim
Journal:  Turk J Urol       Date:  2017-07-31

4.  Imaging evaluation of sorafenib for treatment of advanced hepatocellular carcinoma.

Authors:  Tianying Zheng; Hanyu Jiang; Yi Wei; Zixing Huang; Jie Chen; Ting Duan; Bin Song
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

5.  Preoperative prediction of tumour deposits in rectal cancer by an artificial neural network-based US radiomics model.

Authors:  Li-Da Chen; Wei Li; Meng-Fei Xian; Xin Zheng; Yuan Lin; Bao-Xian Liu; Man-Xia Lin; Xin Li; Yan-Ling Zheng; Xiao-Yan Xie; Ming-De Lu; Ming Kuang; Jian-Bo Xu; Wei Wang
Journal:  Eur Radiol       Date:  2019-12-11       Impact factor: 5.315

6.  Evaluation of liver parenchyma stiffness in patients with liver tumours: optimal strategy for shear wave elastography.

Authors:  Wei Zheng; Zhong-Guo Zhou; Chong-Hei Wong; Xiao-Qing Pei; Shu-Lian Zhuang; Qing Li; Min-Shan Chen; An-Hua Li; Fu-Jun Zhang
Journal:  Eur Radiol       Date:  2018-08-13       Impact factor: 5.315

7.  Diagnostic value of strain elastography for differentiating benign and malignant soft tissue masses.

Authors:  Shilin Li; Lingfang Liu; Guorong Lv
Journal:  Oncol Lett       Date:  2017-06-15       Impact factor: 2.967

Review 8.  Quantitative and noninvasive assessment of chronic liver diseases using two-dimensional shear wave elastography.

Authors:  Li-Ting Xie; Chun-Hong Yan; Qi-Yu Zhao; Meng-Na He; Tian-An Jiang
Journal:  World J Gastroenterol       Date:  2018-03-07       Impact factor: 5.742

9.  Spleen stiffness and volume help to predict posthepatectomy liver failure in patients with hepatocellular carcinoma.

Authors:  Wei Peng; Xiao-Yun Zhang; Chuan Li; Tian-Fu Wen; Lv-Nan Yan; Jia-Yin Yang
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

Review 10.  Ultrasound Elastography: Review of Techniques and Clinical Applications.

Authors:  Rosa M S Sigrist; Joy Liau; Ahmed El Kaffas; Maria Cristina Chammas; Juergen K Willmann
Journal:  Theranostics       Date:  2017-03-07       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.